These results suggested that miR-137 suppresses the translational activity of the Del-1 gene by targeting the binding site in the 3′-UTR of Del-1 mRNA, thereby affecting Del-1 secretion from the breast cancer cells. This evidence concerns the gene EDIL3 and breast cancer.